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INTRODUCTION
METHODS
Patients diagnosed with IPLC between 2000 and 2017 were identified from 
the Karmanos Cancer Institute Tumor Registry and included in this 
retrospective analysis. Individuals who later developed SPLC were 
matched for age, histology and stage to patients with IPLC who did not 
develop SPLC.
Age at first diagnosis, gender, histology, family history, race, smoking 
history, stage of first diagnosis, treatment modality, whether a patient had 
surgery after IPLC diagnosis, and patient living status were collected and  
reviewed. Logistic and Cox regression analyses were performed to identify 
risk factors for SPLC emergence and overall survival. 
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CONCLUSION
Second primary lung cancer (SPLC) is defined as a distinct pulmonary 
malignancy that arises in different segments of the same lobe or different 
lobes, displays different histology, and/or is diagnosed two or more years 
after initial primary lung cancer (IPLC). The risk of development of SPLC after 
an IPLC is about 1% to 2% per patient year. Appropriate surveillance 
recommendations that enable early detection of SPLC are essential for 
increasing life expectancy post treatment of IPLC. Current guidelines for 
monitoring SPLC development are limited. 
The aim of this study was to characterize risk factors associated with the 
development of SPLC. Our intention was to categorize these considerations 




121 patients diagnosed with IPLC who later developed SPLC were identified 
and compared to 120 patients with IPLC who did not develop SPLC. Several 
factors such as stage at first diagnosis, histology, age, and smoking history 
were not associated with SPLC risk (Table 1). Patients who did not undergo 
surgical resection had a significantly lower probability of developing SPLC (OR 
0.235, 95% confidence interval [CI]: 0.118 to 0.450; p<0.001, Table 2). 
Compared to surgical resection patients, individuals who did not have surgery 
as their primary treatment for IPLC had a significantly higher hazard of death 
(HR 3.088, 95% CI: 2.114 to 4.512; p<0.001, Table 3, Figure 1). 
FIGURE 1
Kaplan-Meier curve of OS by the status of second 
diagnosis (Yes vs. No). The median OS is 6.96 years 
(95% CI, 5.17 to 8.32) and 3.09 years (95% CI, 2.11 
to 4.49) for Group 1 (Yes) and Group 2 (No), 
respectively. The median follow-up time of OS is 
13.20 years (95% CI, 11.18 to 16.00) and 10.30 
years (95% CI, 7.84 to 13.30) for Group 1 and 
Group 2, respectively. The follow-up time was 
calculated using the reverse Kaplan-Meier 
estimate.
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We demonstrated that surgical resection at first diagnosis was an important 
factor to consider when screening for SPLC. While healthier individuals were 
likely to be selected for surgical resection, thereby contributing to longer 
survival, these were the patients most likely to develop SPLC and who may 
benefit from lifetime screening. Further prospective studies to better 
characterize SPLC risk factors is essential for implementing effective 
surveillance recommendations at the population level. 
